The European Union will accelerate the approvals of coronavirus vaccines adapted to combat mutations. This was stated by the bloc’s Health Commissioner Stella Kyriakides in an interview with Augsburger Allgemeine, Reuters reports.
“We have now decided that a vaccine that has been improved by the manufacturer on the basis of the previous vaccine to combat new mutations no longer has to go through the entire approval process. So it will be faster to have suitable vaccines available without compromising on safety,” she said.
While vaccinations in the first quarter of 2021 have started slowly, the second quarter would see a pick-up and by the end of September the EU expects to have received sufficient doses from licenced producers to cover over 70% of its population, Kyriakides said.
She also reiterated the Commission view that closing borders was not an effective weapon against infections.
“I think it is wrong for us to return to a Europe with closed borders, as in March 2020,” Health Commissioner noted.